Related Experiment Video

Updated: Jun 1, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

The role of IL-15 in central nervous system disorders

M Rentzos1, A Rombos

  • 1Department of Neurology, Aeginition Hospital, Athens National University, School of Medicine, Greece. mrentzos@med.uoa.gr

Acta Neurologica Scandinavica
|May 28, 2011
PubMed

Insights

Interleukin-15 (IL-15) is a proinflammatory cytokine that supports immune cell activity. Its precise role in neurological diseases like multiple sclerosis, Alzheimer's, and Parkinson's remains unclear, despite potential involvement in microglial activation.

Area of Science:

  • Immunology
  • Neuroscience
  • Cytokine Biology

Background:

  • Interleukin-15 (IL-15) is a proinflammatory cytokine produced by various immune cells.
  • IL-15 influences T-cell proliferation, natural killer (NK) cell activity, and B-cell immunoglobulin secretion.
  • The specific function of IL-15 in central nervous system (CNS) disorders is not well-understood.

Purpose of the Study:

  • To explore the potential involvement of IL-15 in the pathogenesis of neurological diseases.
  • To investigate the role of IL-15 in microglial activation within the CNS.

Main Methods:

  • Review of existing literature on IL-15 and its functions.
  • Analysis of IL-15's known effects on immune cells relevant to CNS inflammation.
  • Correlation of IL-15's properties with inflammatory processes in common neurological disorders.

Main Results:

  • IL-15 is a potent immune modulator with known roles in T-cell and B-cell responses.
  • Microglial cells are key immune regulators in the CNS.
  • IL-15 has the potential to influence microglial activation and inflammatory reactions in CNS diseases.

Conclusions:

  • IL-15 may play a role in the inflammatory pathways of neurological conditions such as multiple sclerosis, Alzheimer's disease, and Parkinson's disease.
  • Further research is required to elucidate the exact role and mechanisms of IL-15 in the pathogenesis of these CNS disorders.

More Related Videos

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues08:47

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Published on: May 8, 2016

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...